0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Kickstarting the Endoscopy Unit after Lockdown Period: Why, When, and How?

      article-commentary

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Endoscopy is an aerosol-generating procedure which poses a high risk of transmission to the endoscopist. Consequently, only urgent and semiurgent endoscopic procedures are being performed since the dawn of the lockdown period. Curbing down the number is the need of the hour and not the choice. It is meant to prepare us to embrace the uncertain conditions in the postlockdown era. In addition, it would allow the judicious use of health care resources like personal protection equipment (PPE) and save them for a time when they are needed the most. In the article, “Way forward: GI Endoscopy Work flow post Lockdown era,” the authors provide with a broad guidance on the strategies of stepwise resumption of endoscopy services in the postlockdown phase. Preparations during the Lockdown Period: “You reap what you sow” The lockdown phase has provided us with an opportunity to prepare and deal with the nuances associated with endoscopies during COVID-19 era. In this period, the gastrointestinal (GI) endoscopy unit should intensify the training of the endoscopist as well as the assistants in methods to prevent transmission of infection to the health care professionals (HCPs). It may not be easy to change practices which have been hardwired over many years. The endoscopy suit should be prepared in such a way that there are minimum extra surfaces (like tables, chairs, writing pads) which may act as potential sources of transmission. In addition, a separate corridor should be created for the transfer of high-risk versus low-risk patients. Endoscopies in the Near Future: The Balancing Act It is likely that the volume of endoscopies in the near future will not be the same as the prepandemic phase. Apprehensions would linger on with the endoscopists as well as the patients scheduled for endoscopies in the postlockdown phase. The approach in the postlockdown phase needs to be a balanced one. A lot of endoscopies would have been cancelled or rescheduled by the time the lockdown phase is over. Consequently, the toll on non-COVID patients may be much higher than presumed.1 The benefit of further delaying these procedures should be weighed and balanced against the risks of denying them repeatedly. Sud et al2 rightly pointed out in this article “Way forward: GI Endoscopy Work flow post Lockdown era” that nonurgent endoscopies cannot be delayed forever and we need to have a blueprint to deal with this situation. The question is “How to go about it”? Well, there is no full proof plan or time-tested strategy here. Uncertainties regarding the duration of lockdown as well as the availability of PPE are major hurdles in the planning a strategic increase in the workflow in GI endoscopy units. The societal guidelines from various GI societies like the Society of Gastrointestinal Endoscopy of India, American Society for Gastrointestinal Endoscopy, Asian Pacific Society for Digestive Endoscopy, and European Society of Gastrointestinal Endoscopy provide guidance on the strategies and precautions required while performing endoscopies during these times.3 4 5 6 To be precise, these are position statements (not guidelines) stressing the fact that our knowledge on this subject is still evolving and these statements are likely to be updated as we get more evidence. Regaining Normalcy in GI Unit: “One Size does not Fit All” The authors aptly mention that the first and the foremost step prior to scheduling an endoscopy is screening of patients and stratifying them into different risk groups according to symptoms, contact, and travel history. It is important to note that presymptomatic CoV-2 infections are not uncommon and constitute the major hurdle for the current screening strategies.7 In addition, the social stigma associated with COVID-19 in our country may pose a special challenge in getting an accurate contact or travel history. Therefore, it may be worth rescheduling the endoscopy after 2 to 3 weeks in case a reliable history cannot be obtained. In this manuscript, the authors suggested that “We should plan to run our facilities at 50% capacity for next 3 months and change it afterwards according to prevailing situation.” However, the strategies to resume normalcy in the postlockdown phase should be individualized in each center. For example, different GI units may not be equal with respect to the age and comorbidity status of HCP, volume of cases, number of health care staff, availability of PPE, and other measures to prevent person-to-person transmission. Some units are known to perform complex and time-consuming therapeutic endoscopic procedures like endoscopic mucosal resections, endoscopic submucosal dissections, therapeutic endosonography procedures, peroral endoscopic myotomy, etc. These procedures by virtue are prone to generate more aerosols than short endoscopic procedures and may pose a higher risk to HCP than short endoscopy procedures. Consequently, the GI units need to devise their own strategies in the postlockdown phase and the “50%” rule may not fit to all. Conclusion In this challenging time, a clear vision is required to allow organization and smooth transition of the endoscopy services to the “new normal” after the lockdown phase is over. The path to normalcy in GI units does not appear to be a straight one and resurgence in COVID-19 cases after the lockdown phase may pose new challenges in this regard. We hope for the best, but need to be prepared for the worst.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

          Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can spread rapidly within skilled nursing facilities. After identification of a case of Covid-19 in a skilled nursing facility, we assessed transmission and evaluated the adequacy of symptom-based screening to identify infections in residents. Methods We conducted two serial point-prevalence surveys, 1 week apart, in which assenting residents of the facility underwent nasopharyngeal and oropharyngeal testing for SARS-CoV-2, including real-time reverse-transcriptase polymerase chain reaction (rRT-PCR), viral culture, and sequencing. Symptoms that had been present during the preceding 14 days were recorded. Asymptomatic residents who tested positive were reassessed 7 days later. Residents with SARS-CoV-2 infection were categorized as symptomatic with typical symptoms (fever, cough, or shortness of breath), symptomatic with only atypical symptoms, presymptomatic, or asymptomatic. Results Twenty-three days after the first positive test result in a resident at this skilled nursing facility, 57 of 89 residents (64%) tested positive for SARS-CoV-2. Among 76 residents who participated in point-prevalence surveys, 48 (63%) tested positive. Of these 48 residents, 27 (56%) were asymptomatic at the time of testing; 24 subsequently developed symptoms (median time to onset, 4 days). Samples from these 24 presymptomatic residents had a median rRT-PCR cycle threshold value of 23.1, and viable virus was recovered from 17 residents. As of April 3, of the 57 residents with SARS-CoV-2 infection, 11 had been hospitalized (3 in the intensive care unit) and 15 had died (mortality, 26%). Of the 34 residents whose specimens were sequenced, 27 (79%) had sequences that fit into two clusters with a difference of one nucleotide. Conclusions Rapid and widespread transmission of SARS-CoV-2 was demonstrated in this skilled nursing facility. More than half of residents with positive test results were asymptomatic at the time of testing and most likely contributed to transmission. Infection-control strategies focused solely on symptomatic residents were not sufficient to prevent transmission after SARS-CoV-2 introduction into this facility.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Coronavirus (COVID-19) outbreak: what the department of endoscopy should know

            Italy recorded its first case of confirmed acute respiratory illness because of coronavirus on February 18, 2020, soon after the initial reports in China. Since that time, Italy and nations throughout the world have adopted very stringent and severe measures to protect populations from spread of infection. Despite these measures, the number of infected people is growing exponentially, with a significant number of patients developing acute respiratory insufficiency. Endoscopy departments face significant risk for diffusion of respiratory diseases that can be spread via an airborne route, including aspiration of oral and fecal material via endoscopes. The purpose of this article is to discuss the measures, with specific focus on personal protection equipment and dress code modalities, implemented in our hospital to prevent further dissemination of COVID-19 infection.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic

              We are currently living in the throes of the COVID-19 pandemic that imposes a significant stress on health care providers and facilities. Europe is severely affected with an exponential increase in incident infections and deaths. The clinical manifestations of COVID-19 can be subtle, encompassing a broad spectrum from asymptomatic mild disease to severe respiratory illness. Health care professionals in endoscopy units are at increased risk of infection from COVID-19. Infection prevention and control has been shown to be dramatically effective in assuring the safety of both health care professionals and patients. The European Society of Gastrointestinal Endoscopy ( www.esge.com ) and the European Society of Gastroenterology and Endoscopy Nurses and Associates ( www.esgena.org ) are joining forces to provide guidance during this pandemic to help assure the highest level of endoscopy care and protection against COVID-19 for both patients and endoscopy unit personnel. This guidance is based upon the best available evidence regarding assessment of risk during the current status of the pandemic and a consensus on which procedures to perform and the priorities on resumption. We appreciate the gaps in knowledge and evidence, especially on the proper strategy(ies) for the resumption of normal endoscopy practice during the upcoming phases and end of the pandemic and therefore a list of potential research questions is presented. New evidence may result in an updated statement.
                Bookmark

                Author and article information

                Journal
                10.1055/s-00043283
                Journal of Digestive Endoscopy
                Thieme Medical and Scientific Publishers Private Ltd. (A-12, Second Floor, Sector -2, NOIDA -201301, India )
                0976-5042
                0976-5050
                March 2020
                : 11
                : 1
                : 92-93
                Affiliations
                [1 ]Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, Telangana, India
                Author notes
                Address for correspondence D. Nageshwar Reddy, MD, DM Asian Institute of Gastroenterology Hyderabad 500082, TelanganaIndia aigindia@ 123456yahoo.co.in
                Article
                JDE20443
                10.1055/s-0040-1712339
                7356653
                58f77955-1b1c-4025-96a9-d90373fe799e

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.

                History
                Funding
                Financial Disclosure None.
                Categories
                Commentary

                Comments

                Comment on this article